GHTC director Jamie Bay Nishi was quoted in a Devex article, exploring the findings of the 2017 G-Finder report, which tracks global investment in neglected disease R&D.
Findings from GHTC's report Return on innovation: Why global health R&D is a smart investment for the United States were cited in an CNBC op-ed authored by Sue Desmond-Hellman, CEO of the Bill & Melinda Gates Foundation.
Huffington Post covered an event hosted by the G20 Health and Development Partnership—of which GHTC is a founding member—aimed at raising the prominence of global health and health R&D on the G20 agenda.
GHTC joined with other members of the global health community in sending a letter to Congressional leaders urging them to raise the non-defense discretionary spending cap as part of fiscal year 2108 budget deal negotiations to allow sustained funding for global health programs through the International Affairs (Function 150) and Health (Function 550) accounts.